See more : Stellar Bancorp, Inc. (STEL) Income Statement Analysis – Financial Results
Complete financial analysis of Jiangsu Nhwa Pharmaceutical Co., LTD (002262.SZ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Jiangsu Nhwa Pharmaceutical Co., LTD, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- PCS Technology Limited (PCS.BO) Income Statement Analysis – Financial Results
- Kronos Advanced Technologies Inc. (KNOS) Income Statement Analysis – Financial Results
- C.S. Lumber Co., Inc (7808.T) Income Statement Analysis – Financial Results
- NobleOak Life Limited (NOL.AX) Income Statement Analysis – Financial Results
- Menhaden Resource Efficiency PLC (MHN.L) Income Statement Analysis – Financial Results
Jiangsu Nhwa Pharmaceutical Co., LTD (002262.SZ)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.nhwa-group.com
About Jiangsu Nhwa Pharmaceutical Co., LTD
Jiangsu Nhwa Pharmaceutical Co., LTD produces and sells central nervous system drugs, and cardiovascular and cerebrovascular drugs in China and internationally. The company offers drugs in the anesthesia, psychiatry, and neurological categories. It also provides APIs in the areas of central nervous system, anesthetic and sedative, and others. The company was founded in 1978 and is headquartered in Xuzhou, China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4.97B | 4.30B | 3.94B | 3.36B | 4.15B | 3.86B | 3.39B | 3.02B | 2.77B | 2.50B | 2.24B | 1.98B | 1.59B | 1.30B | 1.11B | 952.50M | 804.83M | 695.84M | 638.84M |
| Cost of Revenue | 1.37B | 1.02B | 897.33M | 822.11M | 1.55B | 1.69B | 1.77B | 1.63B | 1.61B | 1.51B | 1.34B | 1.23B | 988.04M | 804.95M | 677.14M | 591.50M | 508.84M | 469.66M | 424.45M |
| Gross Profit | 3.60B | 3.28B | 3.04B | 2.54B | 2.60B | 2.17B | 1.63B | 1.39B | 1.16B | 993.69M | 895.83M | 755.70M | 599.46M | 495.66M | 433.80M | 361.00M | 295.99M | 226.18M | 214.40M |
| Gross Profit Ratio | 72.46% | 76.26% | 77.20% | 75.54% | 62.61% | 56.15% | 47.97% | 46.09% | 41.88% | 39.73% | 40.06% | 38.12% | 37.76% | 38.11% | 39.05% | 37.90% | 36.78% | 32.50% | 33.56% |
| Research & Development | 549.32M | 454.25M | 351.73M | 245.86M | 188.97M | 172.03M | 111.38M | 73.20M | 54.79M | 47.64M | 46.24M | 35.06M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 51.57M | 44.19M | 43.49M | 42.78M | 50.38M | 39.32M | 37.87M | 36.06M | 33.39M | 46.58M | 106.14M | 105.02M | 83.31M | 80.60M | 78.97M | 75.05M | 73.31M | 64.16M | 61.50M |
| Selling & Marketing | 1.38B | 1.65B | 1.59B | 1.31B | 1.47B | 1.19B | 941.26M | 815.56M | 660.33M | 557.06M | 542.72M | 455.67M | 372.64M | 309.41M | 272.07M | 215.59M | 169.81M | 132.75M | 120.09M |
| SG&A | 1.90B | 1.70B | 1.64B | 1.35B | 1.52B | 1.23B | 979.13M | 851.62M | 693.72M | 603.64M | 648.86M | 560.69M | 455.96M | 390.01M | 351.03M | 290.63M | 243.12M | 196.92M | 181.59M |
| Other Expenses | -52.92M | 158.95M | 126.23M | 107.95M | 145.48M | -1.70M | -700.06K | 14.47M | 7.20M | 1.84M | 2.35M | 1.83M | 2.36M | 3.26M | 460.77K | 2.21M | 5.36M | 2.19M | 3.43M |
| Operating Expenses | 2.49B | 2.31B | 2.12B | 1.71B | 1.85B | 1.54B | 1.17B | 1.02B | 836.21M | 705.85M | 667.70M | 577.26M | 468.87M | 400.13M | 360.53M | 298.77M | 248.92M | 201.49M | 185.74M |
| Cost & Expenses | 3.86B | 3.33B | 3.01B | 2.53B | 3.41B | 3.23B | 2.93B | 2.65B | 2.44B | 2.21B | 2.01B | 1.80B | 1.46B | 1.21B | 1.04B | 890.27M | 757.76M | 671.15M | 610.18M |
| Interest Income | 23.81M | 25.53M | 17.70M | 26.83M | 26.92M | 30.10M | 15.87M | 13.70M | 5.55M | 6.53M | 4.97M | 3.35M | 3.46M | 2.19M | 3.43M | 3.59M | 1.68M | 935.74K | 1.19M |
| Interest Expense | 4.96M | 4.95M | 5.06M | 1.59M | 15.99M | 13.73M | 8.87M | 11.37M | 17.06M | 19.45M | 17.00M | 13.86M | 10.72M | 7.59M | 9.95M | 14.24M | 11.44M | 9.52M | 8.28M |
| Depreciation & Amortization | 175.10M | 153.75M | 137.85M | 99.34M | 89.98M | 81.73M | 60.25M | 49.97M | 49.58M | 43.73M | 36.70M | 31.98M | 27.65M | 22.41M | 20.26M | 19.51M | 16.53M | 14.35M | 8.59M |
| EBITDA | 1.34B | 1.14B | 1.06B | 948.10M | 876.59M | 708.95M | 515.98M | 393.07M | 368.21M | 324.67M | 259.68M | 211.60M | 159.28M | 120.17M | 93.02M | 83.35M | 67.10M | 40.75M | 33.53M |
| EBITDA Ratio | 26.92% | 27.05% | 27.93% | 28.89% | 21.73% | 19.69% | 15.80% | 14.76% | 13.89% | 13.57% | 12.14% | 10.85% | 10.28% | 9.44% | 8.73% | 9.14% | 8.74% | 5.86% | 6.48% |
| Operating Income | 1.18B | 1.00B | 925.87M | 856.13M | 770.80M | 609.89M | 445.93M | 344.26M | 293.89M | 259.47M | 203.17M | 163.90M | 118.66M | 87.06M | 62.57M | 47.62M | 33.90M | 16.14M | 14.05M |
| Operating Income Ratio | 23.77% | 23.34% | 23.53% | 25.47% | 18.58% | 15.81% | 13.14% | 11.41% | 10.62% | 10.37% | 9.09% | 8.27% | 7.47% | 6.69% | 5.63% | 5.00% | 4.21% | 2.32% | 2.20% |
| Total Other Income/Expenses | -13.70M | -13.56M | -10.09M | -5.66M | -3.70M | -1.70M | -700.06K | 4.51M | 7.08M | 1.44M | 2.18M | -9.25M | 2.25M | -2.82M | 226.07K | -12.63M | -7.94M | 1.72M | 2.61M |
| Income Before Tax | 1.17B | 989.91M | 915.78M | 850.48M | 767.10M | 608.20M | 445.23M | 358.49M | 300.97M | 260.91M | 205.34M | 165.70M | 120.91M | 90.17M | 62.80M | 49.60M | 39.13M | 17.86M | 16.66M |
| Income Before Tax Ratio | 23.50% | 23.03% | 23.27% | 25.30% | 18.49% | 15.76% | 13.12% | 11.88% | 10.88% | 10.43% | 9.18% | 8.36% | 7.62% | 6.93% | 5.65% | 5.21% | 4.86% | 2.57% | 2.61% |
| Income Tax Expense | 134.40M | 109.52M | 117.75M | 123.37M | 110.02M | 89.03M | 69.98M | 56.81M | 45.69M | 39.66M | 32.86M | 27.57M | 15.63M | 15.06M | 9.30M | 9.78M | 12.81M | 2.93M | 1.67M |
| Net Income | 1.04B | 900.71M | 797.78M | 728.82M | 663.31M | 524.81M | 394.63M | 309.74M | 258.35M | 223.27M | 176.25M | 139.70M | 105.65M | 76.44M | 54.67M | 40.70M | 26.66M | 16.98M | 16.82M |
| Net Income Ratio | 20.85% | 20.95% | 20.27% | 21.68% | 15.99% | 13.60% | 11.63% | 10.26% | 9.34% | 8.93% | 7.88% | 7.05% | 6.65% | 5.88% | 4.92% | 4.27% | 3.31% | 2.44% | 2.63% |
| EPS | 1.03 | 0.89 | 0.79 | 0.72 | 0.66 | 0.52 | 0.39 | 0.31 | 0.26 | 0.23 | 0.18 | 0.14 | 0.12 | 0.09 | 0.06 | 0.05 | 0.04 | 0.04 | 0.05 |
| EPS Diluted | 1.03 | 0.89 | 0.79 | 0.72 | 0.66 | 0.52 | 0.39 | 0.31 | 0.26 | 0.23 | 0.18 | 0.14 | 0.12 | 0.09 | 0.06 | 0.05 | 0.04 | 0.04 | 0.05 |
| Weighted Avg Shares Out | 1.01B | 1.01B | 1.01B | 1.01B | 1.01B | 1.01B | 1.01B | 1.01B | 995.11M | 981.20M | 981.33M | 981.23M | 876.06M | 876.22M | 875.98M | 748.37M | 648.69M | 459.22M | 372.19M |
| Weighted Avg Shares Out (Dil) | 1.01B | 1.01B | 1.01B | 1.01B | 1.01B | 1.01B | 1.01B | 1.01B | 1.01B | 981.20M | 981.33M | 981.29M | 876.06M | 876.22M | 875.98M | 748.37M | 648.69M | 459.22M | 372.19M |
No news found for: 002262.SZ
Source: https://incomestatements.info
Category: Stock Reports